Dorian LPG
LPG
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
eBay
EBAY
Lantheus
LNTH
US Stock MarketDetailed Quotes
BIIB Biogen
- 146.790
- -3.850-2.56%
Close Dec 18 16:00 ET
- 146.640
- -0.150-0.10%
Pre 04:59 ET
21.39BMarket Cap13.27P/E (TTM)
151.489High146.575Low1.50MVolume150.010Open150.640Pre Close221.89MTurnover1.03%Turnover Ratio18.42P/E (Static)145.72MShares268.29552wk High1.31P/B21.32BFloat Cap146.57552wk Low--Dividend TTM145.23MShs Float480.180Historical High--Div YieldTTM3.26%Amplitude2.625Historical Low148.321Avg Price1Lot Size
About Biogen Company
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Company Profile
SymbolBIIB
Company NameBiogen
Listing DateSep 17, 1991
Issue Price15.00
Founded1978
CEOMr. Christopher A. Viehbacher
MarketNASDAQ
Employees7570
Fiscal Year Ends12-31
Address225 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-679-2000
Websitehttp://www.biogen.com
Company Executives
- Name
- Position
- Salary
- Christopher A. Viehbacher
- Director, President and Chief Executive Officer
- 4.07M
- Dr. Ginger Gregory, PhD
- Executive Vice President and Chief Human Resources Officer
- --
- Robin C. Kramer
- Senior Vice President and Chief Accounting Officer
- --
- Michael R. Mcdonnell
- Executive Vice President and Chief Financial Officer
- 7.17M
- Susan H. Alexander
- Executive Vice President and Chief Legal Officer
- 6.70M
- Dr. Priya Singhal, M.D.,M.P.H.
- Executive Vice President and Head of Development
- --
- Rachid Izzar
- Executive Vice President, Global Product Strategy and Commercialization
- 5.45M
- Adam Keeney, PhD
- Executive Vice President, Head of Corporate Development
- --
- Nicole Murphy
- Executive Vice President, Pharmaceutical Operations and Technology
- 5.71M
- Dr. Jane Grogan, PhD
- Executive Vice President, Head of Research
- --
- Caroline D. Dorsa
- Chairman of the Board
- 646.13K
- Monish D. Patolawala
- Independent Director
- --
- William A. Hawkins, III
- Independent Director
- 425.73K
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 435.32K
- Professor Menelas Pangalos, PhD
- Independent Director
- --
- Dr. Lloyd Minor
- Independent Director
- --
- Jesus B. Mantas
- Independent Director
- 433.23K
- Susan Langer
- Independent Director
- 334.53K
- Dr. Maria C. Freire, PhD
- Independent Director
- 412.90K
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 418.02K
